Vaccines for Cancer Immunotherapy - 1st Edition - ISBN: 9780128140390, 9780128140406

Vaccines for Cancer Immunotherapy

1st Edition

An Evidence-Based Review on Current Status and Future Perspectives

Editors: Nima Rezaei Mahsa Keshavarz-Fathi
eBook ISBN: 9780128140406
Paperback ISBN: 9780128140390
Imprint: Academic Press
Published Date: 22nd October 2018
Page Count: 198
Sales tax will be calculated at check-out Price includes VAT/GST
193.59
145.19
145.19
145.19
154.87
145.19
145.19
154.87
138.00
103.50
103.50
103.50
110.40
103.50
103.50
110.40
106.00
79.50
79.50
79.50
84.80
79.50
79.50
84.80
120.00
90.00
90.00
90.00
96.00
90.00
90.00
96.00
Unavailable
Price includes VAT/GST

Institutional Subscription

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.

Description

Therapeutic cancer vaccines represent a type of active cancer immunotherapy. Clinicians, scientists, and researchers working on cancer treatment require evidence-based and up-to-date resources relating to therapeutic cancer vaccines. Vaccines for Cancer Immunotherapy provides a reference for cancer treatment for clinicians and presents a well-organized resource for determining high-potential research areas. The book considers that this promising modality can be made more feasible as a treatment for cancer. Chapters cover cancer immunology, general approaches to cancer immunotherapy, vaccines, tumor antigens, the strategy of allogeneic and autologous cancer vaccines, personalized vaccines, whole-tumor antigen vaccines, protein and peptide vaccines, dendritic cell vaccines, genetic vaccines, candidate cancers for vaccination, obstacles to developing therapeutic cancer vaccines, combination therapy, future perspectives and concluding remarks on therapeutic cancer vaccines.

Key Features

  • Introduces the feasible immunotherapeutic vaccines for patients with different types of cancer
  • Presents the status of past and current vaccines for cancer treatment
  • Considers advantages and disadvantages of different therapeutic cancer vaccines
  • Looks at the combination of vaccines and other modalities, including immunotherapeutic and conventional methods
  • Analyzes obstacles to development of therapeutic cancer vaccines
  • Gives a view on future perspectives in the application of therapeutic cancer vaccines

Readership

Interdisciplinary: clinicians, scientists and researchers working on applying different modalities for cancer treatment, including biological therapies; immunologists, oncologists, biotechnologists, and other specialists dealing with cancer research and therapy

Table of Contents

1. Cancer immunology

2. Immunotherapeutic Approaches in Cancer

3. Vaccines, Adjuvants, and Delivery Systems

4. Tumor Antigens

5. Strategy of Allogeneic and Autologous Cancer Vaccines

6. Personalized Cancer Vaccine

7. Whole Tumor Cell Vaccine for Cancer

8. Peptide and Protein Vaccines for Cancer

9. Immune Cell Vaccine for Cancer

10. Genetic Vaccine for Cancer

11. Candidate Cancers for Vaccination

12. Obstacles in the Development of Therapeutic Cancer Vaccines

13. Combination Therapy: Cancer Vaccines and Other Therapeutics

14. Concluding Remarks and Future Perspectives on Therapeutic Cancer Vaccines

Index

Details

No. of pages:
198
Language:
English
Copyright:
© Academic Press 2018
Published:
Imprint:
Academic Press
eBook ISBN:
9780128140406
Paperback ISBN:
9780128140390

About the Editor

Nima Rezaei

Nima Rezaei is professor of clinical immunology at Tehran University of Medical Sciences (TUMS), vice dean of international affairs in the School of Medicine, and deputy president of Research Center for Immunodeficiencies. He received his PhD in clinical immunology and human genetics from the University of Sheffield in the UK after graduation in medicine (MD) from TUMS. He wrote hundreds of papers and edits for leading book series, and is the founding president of Universal Scientific Education and Research Network (USERN), where directing a number of interest groups such the Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA) and the Cancer Immunology Project (CIP).

Affiliations and Expertise

Associate Professor of Clinical Immunology, Tehran University of Medical Sciences, Associate Dean of International Affairs in the School of Medicine, Tehran

Mahsa Keshavarz-Fathi

Mahsa Keshavarz-Fathi is a medical researcher and MD candidate at Tehran University of Medical Sciences (TUMS). She is also the managing director of the Cancer Immunology Project (CIP) and Breast Cancer Association (BrCA) undertaking and managing different research projects in the field of cancer treatment, cancer immunology and immunotherapy.

Affiliations and Expertise

Medical Researcher, Tehran University of Medical Sciences, Tehran

Ratings and Reviews